FDA Guidance for Industry: Bioavailability and Bioequivalence Studies for orally administered drug products - General considerations

Titel:
FDA Guidance for Industry: Bioavailability and Bioequivalence Studies for orally administered drug products - General considerations
Internet:
Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/

Dokumentenart:
Guidance for Industry
Inhalt:
Bioavailability and Bioequivalence Studies for orally administered drug products - General considerations

Zurück